Literature DB >> 33988089

COVID-19 and Long-Term Care Policy for Older People in Japan.

Margarita Estévez-Abe1, Hiroo Ide2.   

Abstract

Japan's initial response to COVID-19 was similar to that of the US. However, the number of deaths in Japan has remained very low. Japan also stands out for the relatively low incidence of viral transmission in Long-Term Care Facilities (LTCFs) compared to both European countries and the United States. We argue that Japan's institutional decision to lockdown Long-Term Care facilities as early as mid-February - weeks earlier than most European countries and the US - contributed to lowering the number of deaths in LTCFs. We highlight a few lessons from the Japanese experience: (i) the presence of hierarchically organized government agencies whose sole missions are elderly care; (ii) the presence of effective communication channels between LTCFs and the regulatory authorities; and (iii) the well-established routine protocols of prevention and control in LTCFs.

Entities:  

Keywords:  COVID-19; Japan; long-term care; nursing homes; public health interventions

Year:  2021        PMID: 33988089     DOI: 10.1080/08959420.2021.1924342

Source DB:  PubMed          Journal:  J Aging Soc Policy        ISSN: 0895-9420


  3 in total

1.  Person-centered dementia care during COVID-19: a qualitative case study of impact on and collaborations between caregivers.

Authors:  Kana Kazawa; Ayuto Kodama; Kaoru Sugawara; Mikio Hayashi; Hidetaka Ota; Daisuke Son; Shinya Ishii
Journal:  BMC Geriatr       Date:  2022-02-07       Impact factor: 3.921

2.  Experiences with COVID-19 cluster infections in geriatric care facilities.

Authors:  Kana Kazawa; Tatsuhiko Kubo; Masahiro Akishita; Shinya Ishii
Journal:  Geriatr Gerontol Int       Date:  2022-05-29       Impact factor: 3.387

3.  Long-term impact of the COVID-19 pandemic on facility- and home-dwelling people with dementia: Perspectives from professionals involved in dementia care.

Authors:  Kana Kazawa; Tatsuhiko Kubo; Masahiro Akishita; Shinya Ishii
Journal:  Geriatr Gerontol Int       Date:  2022-09-06       Impact factor: 3.387

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.